IDiyas

For the Inventor, By the Inventor

Shanghai, China

Xianglin Zhao

USPTO Granted Patents = 9 

 

 

Average Co-Inventor Count = 10.2

ph-index = 3

Forward Citations = 36(Granted Patents)


Location History:

  • Changshu, CN (2013)
  • Shanghai, CN (2016 - 2023)

Company Filing History:

goldMedal9 out of 3,923 
 
Novartis Ag
 patents

Years Active: 2013-2023

where 'Filed Patents' based on already Granted Patents

9 patents (USPTO):
1. 11578053 - Chemical process for preparing phenylpiperidinyl indole derivatives (2023-02-14),
2. 11208398 - Chemical process for preparing phenylpiperidinyl indole derivatives (2021-12-28),
3. 10507201 - Use of ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors (2019-12-17),
4. 10130629 - Pharmaceutical combinations (2018-11-20),
5. 9896449 - Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors (2018-02-20),
6. 9802917 - Particles of N-(5-cyano-4-((2-methoxyethyl)amino)pyridin-2-yl)-7-formyl-6-((4-methyl-2-oxopiperazin-1-yl)methyl)-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxamide (2017-10-31),
7. 9533988 - Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors (2017-01-03),
8. 9266883 - Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors (2016-02-23),
9. 8470878 - Heterocyclic sulfonamide derivatives (2013-06-25),

Title: Innovator Spotlight: Xianglin Zhao

Introduction: Meet Xianglin Zhao, a prolific inventor based in Shanghai, China, with an impressive track record of 9 patented innovations. His latest patents showcase his expertise in chemical processes for preparing phenylpiperidinyl indole derivatives, revolutionizing the pharmaceutical industry with his groundbreaking discoveries.

Latest Patents: Xianglin Zhao's recent patents focus on a novel method for synthesizing a compound of formula (I), known as 4-(((2S,4S)-(4-ethoxy-1-(((5-methoxy-7-methyl-1H-indol-4-yl)methyl)piperidin-2-yl))benzoic acid. These patents encompass the synthesis of intermediates, the pharmaceutical applications of the compound, and its incorporation into pharmaceutical compositions, paving the way for innovative drug development.

Career Highlights: Xianglin Zhao is a valued member of the renowned pharmaceutical company Novartis AG, where he channels his passion for innovation into transformative projects. His commitment to pushing the boundaries of pharmaceutical research has led to a series of groundbreaking patents that have the potential to reshape the industry landscape.

Collaborations: In his professional journey, Xianglin Zhao has collaborated with esteemed colleagues such as Can Wang and Nicole Buschmann. Together, they have leveraged their expertise to drive forward innovative projects, fostering a culture of collaboration and creativity within the pharmaceutical research community.

Conclusion: Xianglin Zhao's dedication to pushing the boundaries of pharmaceutical innovation is evident in his impressive portfolio of patented inventions. His contributions not only showcase his technical prowess but also underscore his commitment to advancing the field for the betterment of society. As Xianglin Zhao continues to make strides in the world of pharmaceutical research, his inventive spirit serves as an inspiration to aspiring inventors and industry professionals alike.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…